Bevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial

BACKGROUND: Brain metastases from breast cancer occur in 20%–40% of patients, and the frequency has increased over time. New radiosensitizers and cytotoxic or cytostatic agents, and innovative techniques of drug delivery are still under investigation. METHODS: Five patients with brain metastases who...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Daigo, Iwase, Satoru, Tsubota, Yu, Sueoka, Noriko, Yamamoto, Chizuko, Kitamura, Kaoru, Odagiri, Hiroki, Nagumo, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459838/
https://www.ncbi.nlm.nih.gov/pubmed/23049262
http://dx.doi.org/10.2147/OTT.S36515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459838/
https://www.ncbi.nlm.nih.gov/pubmed/23049262
http://dx.doi.org/10.2147/OTT.S36515

Ejemplares similares